Modification of paclitaxel-loaded solid lipid nanoparticles with 2-hydroxypropyl-β-cyclodextrin enhances absorption and reduces nephrotoxicity associated with intravenous injection

References

• SinglaAKGargAAggarwalDPaclitaxel and its formulationsInt J Pharm200223517919211879753
   PubMed Web of Science ®Google Scholar
• YonchevaKCallejaPAgüerosMStabilized micelles as delivery vehicles for paclitaxelInt J Pharm201243625826422721848
   PubMed Web of Science ®Google Scholar
• LeeSCHuhKMLeeJChoYWGalinskyREParkKHydrotropic polymeric micelles for enhanced paclitaxel solubility: in vitro and in vivo characterizationBiomacromolecules2007820220817206808
   PubMed Web of Science ®Google Scholar
• KimSCKimDWShimYHIn vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacyJ Control Release20017219120211389998
   PubMed Web of Science ®Google Scholar
• SharmaAMayhewEStraubingerRMAntitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor modelCancer Res199353587758817903197
   PubMed Web of Science ®Google Scholar
• BilensoyEGürkaynakODoğanALHincalAASafety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel deliveryInt J Pharm200834716317017689901
   PubMed Web of Science ®Google Scholar
• TalegaonkarSAzeemAAhmadFJKharRKPathanSAKhanZIMicroemulsions: a novel approach to enhanced drug deliveryRecent Pat Drug Deliv Formul2008223825719075911
   PubMedGoogle Scholar
• DordunooSKJacksonJKArsenaultLAOktabaAMHunterWLBurtHMTaxol encapsulation in poly(epsilon-caprolactone) micro-spheresCancer Chemother Pharmacol1995362792827543028
   PubMed Web of Science ®Google Scholar
• SharmaDChelviTPKaurJNovel taxol formulation: polyvinylpyrrolidone nanoparticle-encapsulated taxol for drug delivery in cancer therapyOncol Res199682812868938791
   PubMed Web of Science ®Google Scholar
• LiXLiPZhangYNovel mixed polymeric micelles for enhancing delivery of anticancer drug and overcoming multidrug resistance in tumor cell lines simultaneouslyPharm Res2010271498151120411408
   PubMed Web of Science ®Google Scholar
• LuoJXiaoKLiYWell-defined, size-tunable, multifunctional micelles for efficient paclitaxel delivery for cancer treatmentBioconjug Chem2010211216122420536174
   PubMed Web of Science ®Google Scholar
• XiaoKLuoJFowlerWLA self-assembling nanoparticle for paclitaxel delivery in ovarian cancerBiomaterials2009306006601619660809
   PubMed Web of Science ®Google Scholar
• ProkopADavidsonJMNanovehicular intracellular delivery systemsJ Pharm Sci2008973518359018200527
   PubMed Web of Science ®Google Scholar
• WissingSAKayserOMullerRHSolid lipid nanoparticles for parenteral drug deliveryAdv Drug Deliv Rev2004561257127215109768
   PubMed Web of Science ®Google Scholar
• SoutoEBMullerRHCosmetic features and applications of lipid nanoparticles (SLN, NLC)Int J Cosmet Sci20083015716518452432
   PubMedGoogle Scholar
• LippacherAMullerRHMaderKInvestigation on the viscoelastic properties of lipid based colloidal drug carriersInt J Pharm200019622723010699724
   PubMed Web of Science ®Google Scholar
• MarengoECavalliRCaputoORodriguezLGascoMRScale-up of the preparation process of solid lipid nanospheres. Part IInt J Pharm200020531311000537
   PubMed Web of Science ®Google Scholar
• MehnertWMaderKSolid lipid nanoparticles: production, characterization and applicationsAdv Drug Deliv Rev20014716519611311991
   PubMed Web of Science ®Google Scholar
• BaekJSSoJWShinSCChoCWSolid lipid nanoparticles of paclitaxel strengthened by hydroxypropyl-β-cyclodextrin as an oral delivery systemInt J Mol Med20123095395922859311
   PubMed Web of Science ®Google Scholar
• BaekJSChoCW2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoing p-glycoprotein function in multidrug resistant breast cancer cellsJ Pharm Pharmacol201365727823215690
   PubMed Web of Science ®Google Scholar
• YamazakiMItoTDeformation and instability in membrane structure of phospholipid vesicles caused by osmophobic association: mechanical stress model for the mechanism of poly(ethylene glycol)-induced membrane fusionBiochemistry199029130913142322565
   PubMed Web of Science ®Google Scholar
• GrattonSERoppPAPohlhausPDThe effect of particle design on cellular internalization pathwaysProc Natl Acad Sci U S A2008105116131161818697944
   PubMed Web of Science ®Google Scholar
• KerrJFWinterfordCMHarmonBVApoptosis. Its significance in cancer and cancer therapyCancer199473201320268156506
   PubMed Web of Science ®Google Scholar
• HanahanDWeinbergRAHallmarks of cancer: the next generationCell201114464667421376230
   PubMed Web of Science ®Google Scholar
• GaoLLiuGMaJWangXZhouLLiXIn vivo performancesJ Control Release201216041843022465393
   PubMed Web of Science ®Google Scholar
• LouHZhangXGaoLIn vitro and in vivo antitumor activity of oridonin nanosuspensionInt J Pharm200937918118619563872
   PubMed Web of Science ®Google Scholar
• GaoLZhangDChenMStudies on pharmacokinetics and tissue distribution of oridonin nanosuspensionsInt J Pharm200835532132718242896
   PubMed Web of Science ®Google Scholar
• MoqhimiSMHunterACMurrayJCLong-circulating and target-specific nanopartricles: theory to practicePharmacol Rev20015328331811356986
   PubMed Web of Science ®Google Scholar
• AliabadiHMShahinMBrocksDRLavasanifarADisposition of drugs in block copolymer micelle delivery systems: from discovery to recoveryClin Pharmacokinet20084761963418783294
   PubMed Web of Science ®Google Scholar
• HaghighiMNematbakhshMTalebiAThe role of angiotensin II receptor 1 (AT1) blockade in cisplatin-induced nephrotoxicity in rats: gender-related differencesRen Fail2012341046105122780575
   PubMed Web of Science ®Google Scholar
• NematbakhshMAshrafiFSafariTAdministration of vitamin E and losartan as prophylaxes in cisplatin-induced nephrotoxicity model in ratsJ Nephrol20122541041721928232
   PubMed Web of Science ®Google Scholar
• ShimedaYHirotaniYAkimotoYProtective effects of capsaicin against cisplatin-induced nephrotoxicity in ratsBiol Pharm Bull2005281635163816141530
   PubMed Web of Science ®Google Scholar
• EvenepoelPAcute toxic renal failureBest Pract Res Clin Anaesthesiol200418375214760873
   PubMedGoogle Scholar
• LameireNVan BiesenWVanholderRAcute renal failureLancet200536541743015680458
   PubMed Web of Science ®Google Scholar
• KoziaraJMWhismanTRTsengMTMumperRJIn-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumorsJ Control Release200611231231916626835
   PubMed Web of Science ®Google Scholar